News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
178
Sources here
23
Companies here
6
Search results Stored financial headlines

Active search

178 matching headlines

Ticker or company: IFAMain company stories
Clear
Latest

MarketBeat Earnings

Equifax, Inc. $EFX Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in Equifax (NYSE:EFX) by 14.0% in the second quarter, selling 5,549 shares but still holding 34,154 shares valued at $5.4 million. Despite the sale, institutional investors own 96.2% of Equifax, and analysts maintain a "Moderate Buy" rating with an average price target of $215.79. The company reported strong Q2 earnings, exceeding EPS …

Equifax Inc. stock underperforms Friday when compared to competitors

Equifax Inc. (EFX) saw its stock fall by 2.55% on Friday, closing at $180.85, a day when the broader market also experienced declines with the S&P 500 Index and Dow Jones Industrial Average dropping. This performance left Equifax Inc. 33.47% below its 52-week high …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake

Citadel entities, including Citadel Securities LLC and Citadel Advisors LLC, along with Kenneth Griffin, have filed an amended Schedule 13G disclosing beneficial ownership of Medifast (MED) common stock. The filing indicates that each reporting person holds less than 5% of Medifast's outstanding shares, with …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Equifax agrees to pay $100 million over allegedly inaccurate credit scores

Equifax Information Services LLC and its parent company, Equifax Inc., have agreed to a $100 million class action settlement over allegations of inaccurate credit scores caused by a 2022 coding error. The settlement, which awaits court approval, would provide an estimated $95 to $280 …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G

Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC have collectively reported a 5.3% beneficial ownership stake in Medifast (MED) through a Schedule 13G filing. This amounts to 587,214 shares of Medifast common stock as of June 30, 2026, including options for 542,700 shares held …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax to pay $100M after 4 million users had their credit scores miscalculated

Equifax has agreed to a proposed $100 million class-action settlement to compensate about 4 million consumers whose credit scores were miscalculated due to a coding error between March 17 and April 8, 2022. The settlement, which still requires federal judge approval, aims to address …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax $100M Settlement Marks Record Payout Over Credit Score Coding Glitch

Equifax has agreed to a $100 million settlement for a class action lawsuit, resolving claims that a coding error in spring 2022 led to inaccurate credit scores for millions of Americans. This nonreversionary settlement is considered the largest resolution ever under the Fair Credit …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medifast (NYSE:MED) Cut to Hold at Zacks Research

Zacks Research downgraded Medifast (NYSE:MED) from "strong buy" to "hold," with Weiss Ratings maintaining a "sell (e+)" rating. The stock has an average "reduce" rating and a consensus price target of $12. Medifast beat earnings and revenue expectations for the last quarter, but still …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

Medifast (MED) has seen its revenues stabilize due to increased coach productivity, which rose for the third consecutive quarter in Q2 fiscal 2026. This improvement, with revenue per active earning coach reaching $6,529, suggests a positive trend despite a declining number of active coaches. …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax Director Barbara Larson Secures 341 Phantom Stock Units as Deferred Compensation

Equifax Director Barbara A. Larson acquired 341 phantom stock units on August 10, 2026, as deferred compensation under the company's Board of Directors Deferred Compensation Plan. These units, which are economically equivalent to Equifax common stock, were acquired in two separate transactions at $158.72 …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medifast (MED): Charles Schwab Investment Management reports 3.6% ownership stake

Charles Schwab Investment Management Inc. has reported a 3.6% beneficial ownership stake in Medifast Inc. This amounts to 396,996 shares of common stock, over which Charles Schwab Investment Management Inc. holds sole voting and sole dispositive power. The filing, a Schedule 13G/A, indicates a …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax National Market Pulse Data Shows U.S. Consumer Top-Line Debt Stabilizing at $18.25 Trillion in Q2 2026 With Delinquencies Improving Across Categories

Equifax's Market Pulse Second Quarter U.S. Consumer Credit Trends report reveals that total U.S. consumer debt reached $18.25 trillion in Q2 2026, marking a 2.1% year-over-year increase, predominantly driven by mortgage and revolving bankcard debt. Despite this growth, the data indicates a stabilization period …

EFX main company EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax, Inc. (NYSE:EFX) Given Average Recommendation of "Moderate Buy" by Analysts

Equifax (NYSE:EFX) has received a "Moderate Buy" consensus recommendation from analysts, with an average 12-month price target of $215.79 despite some recent target reductions. The company surpassed Q2 earnings expectations with adjusted EPS of $2.25 and revenue of $1.70 billion, showing a 10.6% year-over-year …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Seay v. Equifax: Court Rules for Consumer on FCRA Claim Over Retained Dispute Notations

A court has ruled in favor of a consumer in the case of Seay v. Equifax, concerning a Fair Credit Reporting Act (FCRA) claim. The ruling addresses the issue of Equifax retaining dispute notations on a consumer's credit report. This decision is significant for …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax, Inc. $EFX Shares Sold by First Trust Advisors LP

First Trust Advisors LP significantly reduced its stake in Equifax, Inc. (NYSE:EFX) by 54.6% in the first quarter, selling 9,815 shares and holding 8,166 shares valued at $1.47 million. Other institutional investors also adjusted their positions, with notable increases from AXA S.A. and a …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions

Medifast's Q2 earnings surpassed analyst expectations, driven by improved coach productivity and the new Trilivy brand. The company reconfirmed its full-year revenue and EPS guidance. Analysts focused on the Catalyst program's costs and profitability impact, coach reception to Trilivy, and future margin trajectory.

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax Inc (EFX) Stock News Today

This page provides the latest stock news for Equifax Inc (EFX), including its current stock price, market capitalization, and P/E ratio. It also lists recent news articles related to S&P Global Inc, indicating that this page acts as a news aggregator for investment-related content. …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Assenagon Asset Management S.A. Has $58.98 Million Stock Holdings in Equifax, Inc. $EFX

Assenagon Asset Management S.A. significantly increased its stake in Equifax, Inc. (NYSE:EFX) by 160.2% during the second quarter, bringing its total holdings to 371,613 shares valued at approximately $58.98 million. This move is part of broader institutional investor activity in EFX, with several other …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Equifax Inc. (EFX) Affects Rotational Strategy Timing

This article analyzes Equifax Inc. (EFX) through an AI-driven rotational strategy, noting stable neutral readings in shorter horizons which could ease a long-term weak bias. It identifies no clear price positioning signal and compelling upside potential due to the absence of resistance levels above …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Creative Analytics Net 30: Digital Marketing Services, Reports To Equifax Only

Creative Analytics offers digital marketing services on net-30 terms, primarily serving as a way for businesses to build credit history. It reports payment activity solely to Equifax, requiring a minimum monthly spend of $49 to activate this credit reporting. While useful for businesses needing …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax Inc. stock outperforms competitors on strong trading day

Equifax Inc. (EFX) stock rose 3.85% to $182.56 on Friday, outperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also saw gains. Despite the strong trading day, Equifax Inc. remains 32.84% below its 52-week high of $271.84, achieved on …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MEDIFAST INC 2026: Revenue $76.38M, EPS ($0.28) — 10-Q Summary

MEDIFAST INC reported its 2026 quarterly results with a significant decline in revenue to $76.38M from $105.56M a year prior, leading to a net loss of ($3.1M) and diluted EPS of ($0.28). This decline was primarily attributed to a roughly 28% drop in active …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (EFX) Enerflex Ltd. Reports Q2 Revenue $582.0M, vs. FactSet Est of $606.8M

Enerflex Ltd. (EFX) reported its second-quarter revenue at $582.0 million, falling short of FactSet's estimate of $606.8 million. The article also provides recent news and analyst adjustments for Equifax Inc., highlighting various price target changes from different financial institutions. Additionally, it offers a company …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equifax Canada Survey Shows One in Four Canadians Expect to Make Only Minimum Credit Card Payments

Equifax Canada More consumers are using credit and savings for everyday expenses, as households with children and adults under 55 report sharper financial pressures TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- A recent Equifax Canada survey* of over 1,500 Canadians revealed that nearly one …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medifast (MED) Stock Rally Leans On Cash As Coach Base Shrinks

Medifast's stock rallied 34% despite Q2 2026 losses and shrinking revenue, with investors focusing on the company's strong cash position and debt-free balance sheet. Management plans a 10-year metabolic health pivot, aiming to leverage its US$170 million in cash to transition from a declining …

MED main company
Sharemaestro market context Price above Trend Line 52 weeks -19.9% · Next-week setup negative 40.4% MED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Some Equifax Customers Have Less Than a Month to Claim Part of a $2.2 Million Settlement—Here’s Who Qualifies

Equifax has agreed to a $2.2 million settlement for a class action lawsuit alleging incorrect duplicate debt listings on some customers' credit reports between August and September 2022. Approximately 37,000 affected individuals have until September 1st to file a claim, potentially receiving up to …

EFX main company
Sharemaestro market context Price above Trend Line 52 weeks -28.3% EFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context